wellrank.ai
Callen-Lordé logo

Callen-Lordé

First cited by AI Jun 25, 2026

Surfaced organically in AI answers about menopause and women's health. Not yet profiled.

Callen-Lordé is losing the AEO war.

Not cited in a single tracked AI answer since Jun 29, 2026, down from a peak of 2% visibility in menopause and women's health on Jun 25, 2026. This page stays public, and recovery shows here the day it happens.

AI Visibility

Visibility trend

Menopause and women's health, daily share of AI answers mentioning Callen-Lordé, through Jul 6, 2026.

0.0%

Last cited Jun 29, 2026 · peak 2% on Jun 25

By engine

Where Callen-Lordé is strong, and where it is invisible.

  • No engine data yet.

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 1 positive mentions
  • 0 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Callen-Lordé

ChatGPTJun 25, 2026, 13:40 UTC
Can I start HRT in my late 50s or is it too late?

Short answer: No — being in your late 50s does not automatically rule out starting HRT. Whether it’s a good option depends on what kind of HRT you mean (menopausal vs gender‑affirming), your symptoms, medical history, and risk factors. Speak with a clinician to get personalized advice. Brief guidance by context 1) Menopausal HRT (for hot flashes, night sweats, vaginal dryness, bone protection) Timing: Starting HRT within about 10 years of menopause or before age ~60 tends to have the most favorable benefit–risk profile (North American Menopause Society guidance). Many people in their late 50s fall into that window. Benefits: Best treatment for bothersome vasomotor symptoms, improves sleep/mood for some people, and helps prevent bone loss. Risks: Small increased risks of venous thromboembolism (VTE), stroke, and — depending on formulation/duration — breast cancer. These risks vary with age, timing, dose, and route. Safer choices for older people or those with clot risk: transdermal estradiol (patch or gel) has lower VTE risk than some oral estrogens. If you still have a uterus you’ll generally need progestogen alongside systemic estrogen to prevent endometrial cancer; if you’ve had a hysterectomy you may use estrogen alone. Local vaginal estrogen (ring, tablet, cream) treats urinary/genital symptoms with minimal systemic exposure and can be used at any age. Common options and brand examples Transdermal estradiol patches: Climara, Vivelle‑Dot — preferred if clot risk is a concern because of lower VTE risk. Estradiol gel: EstroGel or Divigel — convenient transdermal option. Oral estradiol/estrone: Estrace (oral estradiol) — effective but higher first‑pass liver/coagulation effects. Progesterone: micronized progesterone (Prometrium) — used for endometrial protection; synthetic progestins like medroxyprogesterone acetate (Provera) are alternatives. Vaginal options: Vagifem (tablet), Estring (ring), Estrace vaginal cream — for local urogenital symptoms with low systemic exposure. 2) Gender‑affirming HRT Age is not an absolute barrier. Many trans people start hormones later in life with benefit, but older age increases baseline cardiovascular and clot risks, so evaluation and monitoring are important. Typical transfeminine regimen: estradiol (often transdermal in older patients) ± anti-androgen (spironolactone is common in the U.S.). Typical transmasculine regimen: testosterone injections or gels (Depo‑Testosterone, Aveed, AndroGel). Use specialized gender clinics or experienced providers for safe initiation and monitoring. Where to get care / services to consider Primary care, OB‑GYN, or an endocrinologist experienced in menopause or transgender care. Organizations/clinics: Planned Parenthood (in‑person and telehealth) for both menopause and gender‑affirming care in many areas; Fenway Health and Callen‑Lordé (larger LGBTQ+ health centers) for trans care; telehealth services such as Plume or Folx (for gender‑affirming HRT) and Elektra Health or MenoLabs for menopause support if you prefer virtual care. Follow reputable guidelines: North American Menopause Society (NAMS) and WPATH for transgender care. What your clinician will likely do before starting Review medical history and medications (breast cancer, history of clotting, liver disease, stroke/CVD, uncontrolled hypertension are important). Baseline checks: blood pressure, BMI, lipid panel, fasting glucose, maybe liver tests; mammogram if age‑appropriate; consider DEXA scan if osteoporosis is a concern. Discuss route, dose, and monitoring plan. Start at the lowest effective dose and reassess symptoms/risks periodically. Alternatives For hot flashes: SSRIs/SNRIs (paroxetine, venlafaxine), gabapentin, clonidine can help if hormones aren’t appropriate. For bone health: bisphosphonates, denosumab and lifestyle measures if HRT isn’t used. Next steps If you want, tell me whether you mean menopausal HRT or gender‑affirming HRT and any major health issues (history of blood clots, breast cancer, stroke, heart disease, smoking, etc.), and I can outline likely options and what tests you’ll need. If you prefer, I can help you find local clinics or reputable telehealth services.

Mentioned in position 15 of 19

Read full answer with sources →

Competitive Landscape

Callen-Lordé vs the brands AI recommends alongside it

The real competitive set in Menopause and women's health: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Callen-Lordé logo
Callen-LordéThis brand
0.0%
AndroGel logo
AndroGel

1 shared answers

#95
1.7%
Climara logo
Climara

1 shared answers

#8
16.7%
Divigel logo
Divigel

1 shared answers

#42
5.0%
Elektra Health logo
Elektra Health

1 shared answers

#14
10.0%

Email me when overtakes Callen-Lordé

One email the day the ranks flip. Nothing else.

Sources cited around Callen-Lordé

The sites engines cite in answers mentioning this brand. Win these, win the answer.

    Track Callen-Lordé weekly

    One email a week: rank moves, new competitors, and the answers that changed. No noise.

    Work at Callen-Lordé? Get your AI Visibility Audit.

    See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.